Effect of the bm12 class II mutation on proliferative and cytokine responses of encephalitogenic T cells in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis

Journal of Autoimmunity

Volumn 13, Issue 1, 1999, Pages 3-10

  Gur, Hanan ^a   Mendel, Itzhack ^a   Kerlero De Rosbo, Nicole ^a   Ben Nun, Avraham ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Antigen presentation; Experimental autoimmune encephalomyelitis; MHC class II bm12 mutation

Indexed keywords

CYTOKINE; ENCEPHALITOGENIC PROTEIN; GLYCOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CLONAL ANERGY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032770731     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0308     Document Type: Conference Paper

References (29)

1. Rothbard J.B., Gefter M.L. Interactions between immunogenic peptides and MHC proteins. Ann. Rev. Immunol. 9:1991;527.
2. Jameson S.C., Bevan M.J. T cell receptor antagonists and partial agonists. Immunity. 2:1995;1-11.
3. Evavold B.D., Allen P.M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 252:1991;1308-1310.
4. Windhagen A., Scholz C., Hollsberg P., Fukara H., Sette A., Hafler D.A. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity. 2:1995;373-380.
5. Racioppi L., Ronchese F., Matis L.A., Germain R.N. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1993;1047-1060.
6. Sloan-Lancaster J., Evavold B.D., Allen P.M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen presenting cells. Nature. 363:1993;156-159.
7. Kerlero de Rosbo N., Milo R., Lees M.B., Burger D., Bernard C.C.A., Ben-Nun A. Reactivity to Myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:1993;2602-2608.
8. bmice. Fine specificity and T cell receptor Vb expression of encephalitogenic T cells. Eur. J. Immunol. 25:1995;1951-1959.
9. bmice. Eur. J. Immunol. 26:1996;2470-2479.
10. Kerlero de Rosbo N., Mendel I., Ben-Nun A. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and atypical clinical course, induced in PL/J mice by oilgodendrocyte glycoprotein (MOG)-derived peptide: Preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25:1995;985-993.
11. Ben-Nun A., Mendel I., Bakimer R., Fridkis-Hareli M., Teitelbaum D., Arnon R., Sela M., Kerlero de Rosbo N. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer-1 on MOG-induced disease. J. Neurol. 243:1995;S14-S22.
12. bm12, a new H-2 mutation in the I region of the mouse. J. Exp. Med. 150:1979;1323-1338.
13. bm12gene is evidence for genetic exchange between mouse immune response genes. Nature. 308:1984;551-553.
14. Brown J.H., Jardetzki T., Saper M.A., Samaroui B., Bjorkman B.J., Wiley D.C. A hypothetical model of the foreign antigen binding site of class II histocomatibility molecules. Nature. 332:1988;845-850.
15. bm12molecules. Proc. Natl. Acad. Sci. USA. 89:1992;2940-2944.
16. bm12mice by myelin oligodendrocyte glycoprotein: effect of MHC class II mutation on immunodominant epitope selection and fine epitope specificity of encephalitogenic T cells. J. Neuroimmunol. 96:1999;9-20.
17. Ben-Nun A., Lando Z. Detection of cells responding to myelin basic protein by proliferation and selection of T cell lines functional in mediating experimental autoimmune encephalomyelitis in mice. J. Immunol. 130:1983;1205-1209.
18. bm12genes into B lymphoma cells: molecular and functional analysis of introduced antigens. J. Immunol. 135:1985;1456-1464.
19. bmolecule by site-directed mutagenesis. Proe. Natl. Acad. Sci. USA. 83:1986;747-751.
20. Gur H., Wacholtz M.C., Lie W.R., Lipsky P.E., Geppert T.D. Comparison of the capacity of murine and human class I MHC molecules to stimulate T cell activation. Cell. Immunol. 144:1992;392-406.
21. +cells sensitized to nicotinic acetylcholine receptor. J. Immunol. 147:1991;1484-1491.
22. bm12mice. J. Immunol. 145:1990;94-101.
23. bchain prevents experimental autoimmune myasthenia gravis. Immunogenetics. 21:1985;33-38.
24. Infante A.J., Thompson P.A., Krolick K.A., Wall K.A. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm 12 mutation on T cell recognition of acetylcholine receptor epitopes. J. Immunol. 146:1991;2977-2982.
25. Yang B., McIntosh K.R., Drachman D.B. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis. Clin. Immunol. Immunopathol. 86:1998;45-58.
26. Kersh G.J., Allen P.M. Essential flexibility in the T-cell recognition of antigen. Nature. 380:1996;495-498.
27. Madrenas J., Schwartz R.H., Germain R.N. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proc. Natl. Acad. Sci. USA. 93:1996;9736-9741.
28. Sloan-Lancaster J., Evavold B.D., Allen P.M. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1994;1195-1205.
29. Schwartz R.H. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1996;1-8.